EDGAR Filing Documents for 0001157523-05-003348

Form 10KSB - Optional form for annual and transition reports of small business issuers [Section 13 or 15(d), not S-B Item 405]:

SEC Accession No. 0001157523-05-003348

Filing Date

2005-04-15

Accepted

2005-04-14 18:00:37

Documents

Period of Report

2004-12-31

Document Format Files

Seq	Description	Document	Type	Size
1	PHARMAFRONTIERS CORP. 10-KSB	a4863827.txt	10KSB	158487
2	EXHIBIT 10.6	a4863827ex10_6.txt	EX-10.6	23456
3	EXHIBIT 10.7	a4863827ex10_7.txt	EX-10.7	20277
4	EXHIBIT 10.8	a4863827ex10_8.txt	EX-10.8	24509
5	EXHIBIT 10.12	a4863827ex10_12.txt	EX-10.12	99474
6	EXHIBIT 10.13	a4863827ex10_13.txt	EX-10.13	21954
7	EXHIBIT 10.14	a4863827ex10_14.txt	EX-10.14	74710
8	EXHIBIT 10.15	a4863827ex10_15.txt	EX-10.15	76913
9	EXHIBIT 31.1	a4863827ex31_1.txt	EX-31.1	3680
10	EXHIBIT 31.2	a4863827ex31_2.txt	EX-31.2	3691
11	EXHIBIT 32.1	a4863827ex32_1.txt	EX-32.1	1095
12	EXHIBIT 32.2	a4863827ex32_2.txt	EX-32.2	1104
	Complete submission text file	0001157523-05-003348.txt		510941

Mailing Address 2408 TIMBERLOCH PLACE, SUITE B-7 THE WOODLANDS TX 77380

Business Address 2408 TIMBERLOCH PLACE, SUITE B-7 THE WOODLANDS TX 77380 (281)272-9331

PHARMAFRONTIERS CORP (Filer) CIK: 0001069308 (see all company filings)